InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Molineaux Christopher P., 董事. Director active across 1 company, notably Aclaris Therapeutics, Inc.. Aggregated, 6 filings have been logged. Activity tracked since 15 June 2023. The latest transaction was filed on 20 June 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Christopher P. Molineaux is a Board Member at Aclaris Therapeutics, Inc., a biopharmaceutical company focused on developing dermatological treatments. As a board member, he participates in overseeing the company's strategies and making key decisions. Christopher brings expertise in biopharmacy and product development.